Objective: To determine whether bacterial colonization of drains can be reduced by local antiseptic interventions. Background: Drains are a potential source of bacterial entry into surgical wounds and may contribute to surgical site infection after breast surgery. Methods: After institutional review board approval, patients undergoing total mastectomy and/or axillary lymph node dissection were randomized to standard drain care (control) or drain antisepsis (treated). Standard drain care comprised twice daily cleansing with alcohol swabs. Antisepsis drain care included (1) a chlorhexidine disc at the drain exit site and (2) irrigation of the drain bulb twice daily with dilute sodium hypochlorite (Dakin's) solution. Culture results of drain fluid and tubing were compared between control and antisepsis groups. Results: Overall, 100 patients with 125 drains completed the study with 48 patients (58 drains) in the control group and 52 patients (67 drains) in the antisepsis group. Cultures of drain bulb fluid at 1 week were positive (1+ or greater growth) in 66% (38/58) of control drains compared with 21% (14/67) of antisepsis drains (P = 0.0001). Drain tubing cultures demonstrated more than 50 colony-forming units in 19% (8/43) of control drains versus 0% (0/53) of treated drains (P = 0.004). Surgical site infection was diagnosed in 6 patients (6%)-5 patients in the control group and 1 patient in the antisepsis group (P = 0.06). Conclusions: Simple and inexpensive local antiseptic interventions with a chlorhexidine disc and hypochlorite solution reduce bacterial colonization of drains. Based on these data, further study of drain antisepsis and its potential impact on surgical site infection rate is warranted (ClinicalTrials.gov Identifier: NCT01286168).
Some surgeons recommend postoperative antibiotic prophylaxis until drains are removed, but this practice may select for resistant organisms without impacting the infection rate. [11] [12] [13] In addition, prolonged antibiotic use carries other consequences, including allergic reactions, gastrointestinal intolerance, yeast infections, and Clostridium difficile infection. 14 We hypothesize that bacterial colonization of surgical drains contributes to SSI after breast surgery and that measures of local antisepsis are likely to be well tolerated and effective at reducing drain colonization and SSI rates. Therefore, we undertook a proof of principle, prospective, surgeon-blinded, randomized controlled trial to determine whether simple local antisepsis measures can effectively reduce bacterial colonization of drains after breast surgery.
METHODS

Study Population
After approval by the Mayo Clinic Institutional Review Board, eligible subjects were recruited prospectively from the breast surgical practice at Mayo Clinic in Rochester, MN, between January 2009 and May 2011. Individuals were included if undergoing total mastectomy and/or axillary lymph node dissection for benign or malignant disease in which surgical drains were placed. Subjects were ineligible if they were pregnant, had received antibiotics within 14 days before surgery, had a known allergy to chlorhexidine, or were undergoing immediate reconstruction (because of the common use of postoperative antibiotics in this subgroup).
Randomization
After informed consent, subjects were randomized to either the standard drain care regimen or the drain antisepsis regimen by a computerized randomization program, using dynamic allocation and stratifying by surgical procedure (mastectomy or lumpectomy with axillary dissection), surgeon, and body mass index (BMI <30 or ≥30). In the event of bilateral procedures, patients with a unilateral cancer had sample collection and analysis from the side affected with cancer. Subjects who had bilateral cancer or bilateral prophylactic mastectomies underwent computerized randomization to select the side to be evaluated on study. The operating surgeon remained blinded to the assigned treatment arm.
Drain Care Regimens
Study subjects and family members received personal instruction on drain care on the first postoperative day (POD) by the nurse study coordinator, and they were advised not to divulge the drain care regimen to their surgeon. All subjects in both treatment arms were instructed to strip the drain tubing, empty the bulb, and record fluid volume at least twice daily. Individuals assigned to standard drain care were also advised to cleanse the drain exit site with prepackaged 70% isopropyl alcohol wipes twice daily and to cover the drain site with a sterile gauze dressing. Subjects in the drain antisepsis arm were shown how to cleanse the drain exit site with alcohol and then apply a chlorhexidine gluconate disc dressing (Biopatch R ; Johnson & Johnson Medical) at the drain site and secure it with an adherent sterile transparent occlusive dressing (Fig. 1) . The chlorhexidine disc and occlusive dressing were changed every 3 days until drain removal. In addition, subjects in the drain antisepsis arm were instructed to perform antiseptic irrigation of the drainage bulb twice daily as follows: instill 10 mL of dilute Dakin's solution (0.0125% buffered sodium hypochlorite) into the drainage bulb via the exit valve (prepped with alcohol), swish occasionally over 10 minutes, and then empty and return the bulb to suction. At the time of showering, the chlorhexidine disc/occlusive dressing was left intact.
Management of Multiple Drains
If more than 1 drain was placed per surgical site (ie, 2 drains in the setting of a modified radical mastectomy), then both drains associated with that surgical site were treated according to the assigned treatment arm. Each drain associated with the surgical site was evaluated separately for bacterial colonization endpoints.
Follow-up Visits and Cultures
For 30 days after operation, a standardized data collection form was completed at every follow-up visit, with details including drainage volume, erythema, or skin changes at the incision and drain sites, and evidence of seroma or infection. In addition, the medical record was reviewed to screen for late infections. Blinding of the surgeon was maintained at postoperative visits by the study coordinator removing all dressing materials before surgeon evaluation. A mandatory follow-up visit occurred at 1 week (on POD 7 ± 1 day) for study cultures and for clinical evaluation for signs of infection or adverse reactions to drain antisepsis regimen. If drains were ready for removal before this, all cultures were obtained on the day of drain removal. At each visit, compliance with the antiseptic interventions was assessed FIGURE 1. Chlorhexidine disc dressing with occlusive adherent dressing.
by the study coordinator, who asked the subjects whether they had any difficulties that prevented completing the prescribed regimen. For patients with clinical evidence of infection, diagnostic cultures and antibiotic therapy were performed per routine clinical care. Guidelines for drain removal specified output of 30 mL or less per 24 hours for 2 consecutive days or at POD 19, whichever came first. If drain removal did not occur at the 1-week visit, then a repeat culture of drain fluid was obtained on the day of drain removal; therefore, some subjects had drain fluid cultures at 2 time points. Drain tubing cultures at removal were added to the protocol after the study was underway and are available in 76 of 100 patients.
Microbiology
At the 1-week visit, a 2-mL sample of drain fluid from the bulb was obtained aseptically for semiquantitative aerobic and anaerobic cultures. On the day of drain removal, cultures were obtained of both drain bulb fluid and drain tubing. Drains were removed in a sterile fashion after chlorhexidine preparation and sterile draping of the drain exit site. A 5-cm portion of the subcutaneous drain tubing was harvested, starting approximately 1 to 2 cm internal to the skin exit site.
For drain fluid culture, 1 to 2 drops of fluid were inoculated onto sheep blood, eosin methylene blue, and colistin-nalidixic acid agar plates, and anaerobic sheep blood agar plates, and 1 mL of drain fluid was inoculated into thioglycollate broth. The aerobic agar plates were incubated at 35
• C in 5% to 7% CO 2 for 4 days, or until positive. The anaerobic agar plate was incubated anaerobically for 7 days, or until positive. The thioglycollate broth was incubated anaerobically for 14 days, or until positive. Growth was reported as negative, growth from broth only, or if there was growth on a plate, it was quantitated as 1+, 2+, 3+, or 4+ according to standardized laboratory protocol. All isolates were speciated.
For drain tubing culture, the tube was rolled over the surface of a sheep blood agar plate 4 times in different directions, 15 and the plate incubated aerobically at 35
• C in 5% to 7% CO 2 for 4 days, or until positive. Growth was identified and reported semiquantitatively as less than 10 colony-forming units (CFUs), 10 to 19 CFUs, 20 to 50 CFUs, 51 to 100 CFUs or greater than 100 CFUs. Laboratory personnel were blinded to patients' drain care regimens, and results of study cultures were not reported or included in the participants' medical records.
Endpoints and Statistical Power
The primary endpoint of the study was bacterial growth in the fluid of the drainage bulb at the 1-week follow-up visit. Estimating a bacterial colonization rate of 33% in drainage fluid at 1 week, a sample size of 100 was projected to provide 80% power to detect a 70% reduction in colonization with antisepsis measures. A drain fluid culture with bacterial growth of 1+ or greater was defined as positive on the basis of the assumption that growth from broth only should not be clinically meaningful. A positive drain tubing culture was defined as growth of greater than 50 CFU on the basis of prior published data demonstrating catheter site inflammation in a majority of subjects with greater than 50 CFU. 15 Given the limitations in selecting these cutoffs, we examined endpoints not dependent on the chosen cutoff for positivity; the ordinal quantification of degree of colonization was also analyzed for both drain fluid and drain tubing cultures. In samples colonized with multiple organisms, the highest degree of quantification across all organisms was used to classify the sample for analysis. SSIs included any of the following within 30 days after operation: purulent drainage, positive aseptically collected culture from the wound, signs of inflammation with opening of incision and absence of a negative culture, or physician diagnosis of infection (which could include cellulitis). Cases of equivocal SSI were reviewed Copyright © 2013 Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
in detail by the research team without knowledge of the assigned treatment arm and were decided by consensus.
Statistical Analysis
Two sample comparisons at the per patient level were performed using 2-sample t tests or Wilcoxon rank sum tests for continuous and ordinal variables and likelihood ratio χ 2 tests for nominal variables. Drain duration and volume were compared using linear mixed effects models to account for multiple drains within patient. Colonization rates were analyzed on a per drain level with generalized linear mixed models (random intercept logistic regression) to account for the nonindependence of multiple drains from the same patient. Ordinal colonization quantification levels were compared between treatment arms using a generalized estimating equations approach to fit ordinal logistic regression. A per patient analysis of drain colonization was also performed, as was a comparison of SSI rates, using χ 2 tests. The sign test for paired proportions was used to compare positivity rates between mastectomy and axillary drains in patients who had both. P values of <0.05 were considered statistically significant. Analysis was performed using SAS (Version 9.2; SAS Institute Inc, Cary, NC).
RESULTS
One hundred thirteen patients were enrolled with 13 of them excluded before study completion for various reasons including the following: difficulties with returning for drain removal (travel distance/bad weather (6), patient consented but changed their mind on POD 1 (3), patient prescribed antibiotics between time of consent and surgery (2), patient had immediate reconstruction (1), and significant language barrier (1).
The remaining 100 patients with 125 drains completed the study. Forty-eight women (58 drains) were randomized to the control group and 52 women (67 drains) to the antisepsis group. The control and antisepsis groups were similar with respect to age, BMI, American Society of Anesthesiologists (ASA) class, prior chemotherapy or radiation, smoking, preoperative skin prep, operative time, day of drain removal, and drain volume (Table 1 ). Total mastectomy with or without sentinel node biopsy axillary node dissection, and modified radical mastectomy were performed in 66, 6, and 28 patients, respectively. Median duration of drain use was 7 days (range, 4-19 days), with a median output of 23 mL (range, 3-136 mL) for the preceding 24 hours at the 1-week visit and a median of 19 mL (range, 3-57 mL) for the 24 hours before drain removal.
Colonization of Drain Fluid at 1 Week
Cultures of drain bulb fluid at 1 week in the treated group showed significantly less bacterial growth than those in the control group. At the cutoff of 1+ or greater growth for drain fluid cultures, 21% (14/67) of treated drains were positive compared with 66% (38/58) of control drains (P = 0.0001). Analysis performed on a per patient basis showed a similar result with 13 of 52 (25%) patients on the antisepsis arm experiencing 1+ or greater colonization on any drain compared with 31 of 48 (65%) patients on the control arm (P < 0.0001). To examine an analysis not dependent on the choice of cutoff, the ordinal quantification result was also compared between the 2 groups ( Table 2 ) and again demonstrated strong statistical significance (P < 0.0001). In drains removed after the 1-week visit, a second culture was obtained at drain removal. All drains positive (≥1+) at 1 week were also positive at drain removal, with at least 1 organism in common between the 2 cultures for 11 of 14 (79%).
Colonization of Drain Tubing
Drain tubing was cultured at the time of drain removal from 76 subjects (96 drains-43 control and 53 antisepsis). Using a cutoff value of 50 CFU, drain tubing cultures were positive in 0% (0/53) of treated drains compared with 19% (8/43) of control drains (P = 0.004). In a per patient analysis, 0 of 40 patients in the antisepsis group demonstrated greater than 50 CFU colonization for any drain compared with 7 of 36 (19%) patients in the control arm (P = 0.0008). Treating degree of colonization as an ordinal variable (see Table 2 ) also resulted in a statistically significant difference between the treatment arms (P = 0.04). Subjects in the drain antisepsis group were much less likely to have high levels of bacterial colonization in the drain fluid, and none of them had greater than 50 CFU from drain tubing. Among drains with positive bulb fluid cultures (≥1+) at the time of drain removal, the drain tubing was also positive (>50 CFU) in 28% of control drains versus 0% of antisepsis drains. Conversely, among the 8 drains (7 patients) with positive tubing cultures (all in the control group), all 8 had ≥1+ growth in drain fluid, and 7 of 8 had the same organism in both fluid and tubing.
Multiple Drains
Twenty-five patients (10 control, 15 antisepsis) had 2 ipsilateral drains. Regarding fluid cultures, the 2 bulb fluid cultures at 1 week were concordant for 20 drain pairs (12 negative, 8 positive) and discordant for 5; 4 of 5 discordant drain pairs were positive (≥1+) for the mastectomy drain fluid but not for the axillary drain fluid. The difference in positivity rate was not significant (P = 0.38), and the κ agreement statistic was 0.60. Similar results were observed for tubing cultures among the 20 cases with both a mastectomy drain and an axillary drain. The tubing culture results were concordant for 19 pairs (18 with both drain tubing cultures negative, 1 pair with both positive) and discordant for 1 patient who had a positive axillary drain at greater than 100 CFU but a mastectomy drain with growth of only 20 to 50 CFU (below the 50 CFU of positivity and therefore negative).
Bacterial Colonization and Drain Duration
In the control group, bacterial colonization was a timedependent phenomenon and increased in frequency with longer duration of drain presence, both for bulb fluid and drain tubing (Fig. 2) . In the antisepsis group, positive fluid cultures also increased in frequency over time but were less frequent than those in the control group at all time intervals. Tubing cultures in the antisepsis group remained negative at all time points.
Microbiology
A wide variety of microorganisms were identified in bulb fluid, with 35% of cultures demonstrating multiple organisms (Table 3) . Staphylococci were the most common recovered (71%), predominantly coagulase-negative staphylococcus with some Staphylococcus aureus. Gram-negative rods and anaerobes were identified with lower frequency. Drain tubing showed less variation in types of microorganisms, with Staphylococcus species the most common.
Drain Site Erythema and Colonization
The extent of erythema in the skin around the drain exit site as a radial measurement was significantly less among subjects in the antisepsis group than in the control group (mean 1.1 mm vs 2.6 mm, P = 0.001) at 1 week. Although drains with positive (>50 CFU) tubing cultures on average had greater drain site erythema (mean 4.4 mm vs 1.1 mm, P = 0.86), as did patients with SSI (mean 3.0 mm vs 2.1 mm, P = 0.41), neither of these comparisons reached statistical significance. control group, 2 had abscesses that required incision and drainage, and a third demonstrated cellulitis with a positive culture. The remaining 2 patients with SSIs had cases of cellulitis without cultures, but at the time of treatment they were judged by a physician blinded to the study group to represent infection, were treated with antibiotics, and improved on antibiotic therapy, thus on final review these were deemed to be SSIs.
There was only 1 case of SSI that occurred in the drain antisepsis group, presenting with symptoms on POD 31. That patient started chemotherapy on POD 21 and developed fever of unknown origin on POD 31, with localized signs of axillary infection developing over the next week leading to incision and drainage of an axillary abscess. Because the patient's symptoms began just outside the standard 30-day time frame of the Centers for Disease Control and Prevention definition, it is debatable whether this SSI should be included or not, but we included it for a conservative assessment of the differences between the control and antisepsis groups. Therefore, with 5 SSIs among 48 women in the control group and 1 SSI among 52 subjects in the antisepsis group, the difference in the SSI rate between the 2 groups (10.4% vs 1.9%) was not statistically significant but showed a strong trend (P = 0.06). If this case of SSI in the antisepsis group is excluded because of its occurrence after 30 days, then the SSI rate in the control group (10.4%) is significantly higher than that in the antisepsis group (0%), P = 0.01.
Correlation of SSI and Degree of Drain Colonization
Although the analysis was limited by a small number of SSIs, the trend was that SSI occurred more frequently among subjects with greater bacterial colonization, in either drain fluid or drain tubing, compared with those with less or no bacterial colonization. Among patients with heavy (4+) bacterial growth in drain fluid from any drain at 1 week, the SSI rate was 2 of 9 (22%) compared with those with less heavily colonized fluid or no growth (4/91 = 4%, P = 0.08). Similarly, the SSI rate was 2 of 7 (29%) for subjects with tubing growth greater than 50 CFU in any drain compared with 3 of 69 (4%) for those with fewer CFU or no growth (P = 0.05).
Intervention Toxicity and Compliance
There were no allergic reactions to the chlorhexidine disc. upon subjects' reports; at the 1-week follow-up visit and beyond, there were no subjects who reported any compliance failures with the interventions. Two subjects felt unsure about their ability to perform the chlorhexidine disc dressing change. Both of these subjects returned to the clinic for study coordinator assistance with the first dressing change; one performed dressing changes independently after that, and the other subject elected to return for study coordinator assistance with the remaining dressing changes.
DISCUSSION
In this study, we demonstrated that local measures of antisepsis significantly reduce bacterial colonization of surgical drains after breast and axillary surgery, both in the fluid of the drainage bulb and in the subcutaneous portion of the drain tubing. This work provides proof of principle that simple and inexpensive local care measures deserve further study in clinical trials as a means to reduce SSI. SSIs result in increased cost and morbidity and therefore have gained national attention with programs established to minimize these events. 16, 17 The frequency of SSI after breast and axillary surgery in many studies is higher than would be expected for "clean" cases. [1] [2] [3] [4] [5] [6] In 2 recent multicenter prospective studies, the SSI rates after axillary dissection (including cases of cellulitis) were 8% and 14%. 18, 19 Reasons for these higher than expected rates remain undefined but are likely multifactorial. In addition to true differences in the SSI rate, apparent differences may also exist because of SSI definition (eg, whether cellulitis cases are included or excluded) 20 and differences in surveillance methods to ascertain SSI cases. 9, 21 The presence of a surgical drain and its prolonged presence have been associated with increased risk of infection, 5, 9, 10 which is logical because surgical drains provide a conduit for bacterial entry into the wound environment. A recent study investigated rates of bacterial colonization in surgical drains after mastectomy and found that drain fluid is colonized with bacteria in 33% of drains at 1 week after mastectomy and in 81% by 2 weeks. 22 Furthermore, among patients who developed an SSI, the microorganism identified was the same as that previously identified in the drain fluid cultures in 85% of cases. These findings strongly implicate the surgical drain as a source of bacteria that contributes to SSI.
Many risk factors associated with SSI after breast and axillary surgical procedures are host-related (BMI, diabetes, smoking, etc), [6] [7] [8] [9] but few of these can be modified within the preoperative time frame of a few weeks that is common after a diagnosis of early-stage breast cancer. However, the presence and duration of a surgical drain are clinical factors that may be modified to reduce infection risk. Surgical drains can be removed earlier in the postoperative course or omitted altogether, but the theoretical benefit of reduced infection risk without drains would result in an increased frequency of seroma formation, [23] [24] [25] which in turn has also been associated with increased risk of SSI. 26 Therefore, working under the assumptions that drains after mastectomy and axillary dissection are necessary and provide a source of bacterial entry causally related to SSI, 22 we hypothesized that mitigating bacterial colonization of drains may help reduce SSI.
Although some surgeons prescribe systemic antibiotics in the postoperative period after mastectomy with the intent to reduce infection risk associated with indwelling drains, 27 ,28 the efficacy of this strategy is unproven and carries other risks. 29, 30 Therefore, we selected an approach of local antiseptic measures to minimize the bacterial burden of the drain and subcutaneous wound.
Local antisepsis for indwelling drains is logical and extrapolated on the basis of an extensive experience with its use to prevent †Percentages collectively are more than 100% because some samples had more than 1 isolate. Among 82 drain fluid samples with microbial growth, 29 (35%) had more than 1 organism; among 19 drain tubing samples with microbial growth, 3 (16%) grew more than 1 organism.
‡Corynebacterium species includes organisms identified as non-spore-forming gram-positive bacillus resembling Corynebacterium (n = 5), gram-positive bacillus (n = 2), and bacillus (n = 4).
§Corynebacterium species includes organisms identified as non-spore-forming gram-positive bacillus resembling Corynebacterium (n = 2) and gram-positive bacillus (n = 1). intravascular catheter-related infections (CRIs). Research on CRIs demonstrates that the majority of infections with short-term intravascular devices are related to extraluminal migration of bacteria along the catheter, whereas intraluminal contamination is responsible for infections in most permanent intravascular devices. 31 Reducing CRIs is successfully approached with a bundled approach of interventions that target both possible routes of bacterial access. 32 In the case of surgical drains, bacteria may also access the wound environment via both extraluminal and intraluminal routes; the relative contributions of these routes to SSI risk is unknown. For this reason, antiseptic approaches to target both extraluminal and intraluminal colonization in this proof-of-principle trial were used. The chlorhexidine disc dressing was included on the basis of existing evidence of its efficacy in reducing CRIs. 33, 34 In addition to the chlorhexidine disc dressing, we added hypochlorite rinses of the drain bulb, a reservoir that is intermittently opened to the external environment for emptying. This intervention was included on the basis of evidence of reduced bacteriuria after acetic acid irrigation of urinary drainage reservoirs in patients with long-term indwelling urethral catheters. 35 Dilute Dakin's solution for drain bulb irrigation was selected for use because of its broad antimicrobial spectrum, its tradition of use in clinical practice for infected wounds, and its low toxicity profile. [36] [37] [38] Our data demonstrate that bacterial colonization of the drain bulb and subcutaneous drain tubing can be reduced with local, nontoxic antiseptic measures. Our findings also suggest that this might translate into reduced SSI rates. However, the findings must be interpreted with appropriate caution because the study was not powered to a primary endpoint of SSI, and our findings on SSI did not reach statistical significance. Therefore, although the findings are encouraging, we cannot assume that these interventions will reduce SSI. Furthermore, although the antiseptic interventions dramatically reduced bacterial colonization of the surgical drains, culture results varied in the small number of SSIs that occurred, with some individuals developing infection in the presence of negative drain fluid and tubing cultures and the converse situation-a small number of individuals with "heavier" bacterial growth who did not develop infection. It is tempting to speculate that these findings suggest host factors and likely play an important role in the development of SSI. Individuals with host factors conferring increased risk (increased BMI, smoking, immunosuppression) may have lower thresholds for the burden of bacteria that can be tolerated before manifesting as a clinical infection. Our study was not powered to separately analyze these subsets. Another limitation of this study is the combination of 2 interventions to address possible bacterial entry into the mastectomy/axillary dissection wound environment, so we are unable to determine the relative contribution of each route of contamination to SSI, and we could not assess the independent effects of each intervention.
These interventions are simple to perform, easy to learn, have low toxicity, and are relatively inexpensive. These methods could also be applied to other surgical procedures in which drains are required and in which the consequences of infection are high, for example, groin dissection, ventral hernia repair with mesh, and breast reconstruction with implants. With proof of principle that drain antisepsis may reduce SSI by reducing bacterial colonization of drains, we intend to pursue a larger randomized trial powered to an endpoint of SSI.
